Arrowhead Pharmaceuticals

-$2.24 (-3.32%) As of 3:02 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARWR and other ETFs, options, and stocks.

About ARWR

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC.

CEO
Christopher Richard Anzalone
Employees
329
Headquarters
Pasadena, California
Founded
1989

ARWR Key Statistics

Market cap
6.82B
Price-Earnings ratio
—
Dividend yield
—
Average volume
822.46K
High today
$67.50
Low today
$64.04
Open price
$67.15
Volume
67.55K
52 Week high
$93.66
52 Week low
$57.92

ARWR Earnings

-$0.61
-$0.35
-$0.09
$0.17
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
-$0.10 per share
Actual
-$0.61 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure